Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Cost of Revenue: 2023-2024

Historic Cost of Revenue for Krystal Biotech (KRYS) over the last 2 years, with Dec 2024 value amounting to $20.1 million.

  • Krystal Biotech's Cost of Revenue fell 36.22% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 19.03%. This contributed to the annual value of $20.1 million for FY2024, which is 548.38% up from last year.
  • As of FY2024, Krystal Biotech's Cost of Revenue stood at $20.1 million, which was up 548.38% from $3.1 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Cost of Revenue registered a high of $20.1 million during FY2024, and its lowest value of $3.1 million during FY2023.
  • Its 2-year average for Cost of Revenue is $11.6 million, with a median of $11.6 million in 2023.
  • Data for Krystal Biotech's Cost of Revenue shows a peak YoY skyrocketed of 548.38% (in 2024) over the last 5 years.
  • Over the past 2 years, Krystal Biotech's Cost of Revenue (Yearly) stood at $3.1 million in 2023, then skyrocketed by 548.38% to $20.1 million in 2024.